HER2+ Breast Cancer Pilot Study
February 9, 2023 Blood was drawn from 16 breast cancer patients and enriched for Circulating Tumor Cells (CTCs) using LiquidScan. Isolated cells were analyzed for HER2 positivity [Read More...]
BioFluidica Exhibits and Presents at PMWC 2023 in Santa Clara, CA
February 9, 2023 BioFluidica attended the Precision Medicine World Conference (PMWC) 2023 on January 25-27th. Every year PMWC gathers top researchers and medical professionals from all over [Read More...]
BioFluidica Exhibits at AMP 2022 in Phoenix, Arizona
November 1 - 5 BioFluidica attended the Association for Molecular Pathology (AMP) 2022 Annual Meeting and Expo this week, showcasing their LiquidScan technology. AMP is the leading [Read More...]
Liquid Biopsies Take Center Stage at 2022 ASCO Annual Meeting
By Jamie Reno, June 15, 2022 BioFluidica presented its LiquidScan, a microfluidic chip that searches a blood sample for rare biomarkers such as CTCs (circulating tumor cells), cell-free [Read More...]
BioFluidica Attends and Exhibits at ASCO Annual Meeting
June 3 - 7, 2022 BioFluidica attended the ASCO Annual Meeting, exhibiting at Booth 21160 and presenting a poster abstract about the results of a patient sample [Read More...]
BioFluidica turns to blood for accurate, inexpensive cancer tests
San Diego Union Tribune | By Bradley J. Fikes, August 31, 2018 Blood is hard to beat for detecting disease. This liquid tissue circulates throughout the body, picking up [Read More...]